Lim Susan M L - Department of Orthopaedic Surgery, National University of Singapore

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 428 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase II Study of Tepotinib in Patients with Advanced Solid Cancers Harboring MET Exon 14 Skipping Mutations or Amplification (KCSG AL19-17)

E. J. Kang,Y. Yang,S. Lee,Y. J. Kim,S. M. Lim,M. -J Ahn, Y. J. Choi, Y. Lee,T. M. Kim,I. Kim,H. K. Ahn,H. -C Jeung,S. I. Lee,S. Y. Oh,W. K. Bae,H. Ryu,K. H. Park,K. H. Lee

ESMO Openno. 9 (2024): 103668-103668

引用0浏览0WOS引用

LBA13 Dostarlimab + Chemotherapy (CT) Vs Pembrolizumab + CT in Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Updated Asian Subgroup Analyses of the PERLA Trial

D. H. Lee,J. S. Ahn,S-H. Lin, M. Ulanska, G. A. Lopez,C-F. Chian,L. Cho,Z. Szijgyarto,N. Stjepanovic,S. M. Lim

ANNALS OF ONCOLOGY (2023): S1662-S1663

引用0浏览0引用

EP12.01-47 Lazertinib in Pretreated Epidermal Growth Factor Receptor T790M-Mutated Advanced Non-small Cell Lung Cancer: A Real-World Multicenter Study

B-C. Ahn,H. Kim, J. Lee, J.B. Lee,M.-H. Hong,H.R. Kim,B.C. Cho,S.M. Lim

Journal of Thoracic Oncologyno. 11 (2023): S659-S660

引用0浏览0引用

Comparative Analysis of Three NGS Platforms Assessing Tumor Mutational Burden and Mutational Landscape in Resectable Non-Small Cell Lung Cancer

J. B. Lee, S. J. Choi, J. H. Kim,M. H. Hong,B. C. Cho,S. M. Lim

ANNALS OF ONCOLOGY (2023): S1649-S1649

引用0浏览0引用

Cu-64-DOTA-Rituximab PET/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression

Inki Lee,Ilhan Lim,Kyo Chul Lee,Hye Jin Kang,Sang Moo Lim

Clin Nucl Med（2023）

引用1浏览0WOS引用

P2.11-01 A Phase II Study of Tepotinib in Advanced Solid Cancers with MET Exon 14 Skipping Mutation or Amplification; Results of Non-small Cell Lung Cancer

Y. Yang,E.J. Kang, S. Lee,Y.J. Kim,S.M. Lim,M.-J. Ahn,Y.J. Lee,T.M. Kim,I. Kim,H.K. Ahn,H.C. Jeung,S.I. Lee,S.Y. Oh,W.K. Bae,H. Ryu,K.H. Park,K.H. Lee

Journal of Thoracic Oncologyno. 11 (2023)

引用0浏览0引用

MA11.11 Drug Tolerant Persister Cells to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer Harboring EGFR Mutations (NORA)

J. B. Lee, S. J. Choi, Y. J. Park, K. -H. Park, S. H. Yong,H. S. Shim, B. J. Park, C. Y. Lee, S. K. Cheung,S. Sudhaman,S. Velichko,M. Krainock,H. Sethi, M. C. Liu,M. H. Hong,B. C. Cho,S. M. Lim

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S140-S141

引用0浏览0引用

A Phase II Study of Tepotinib in Advanced Solid Cancers with MET exon 14 Skipping Mutation or Amplification; Results of Non-small Cell Lung Cancer

Y. Yang,E. J. Kang,S. Lee, Y. J. Kim,S. M. Lim,M. -J. Ahn,Y. J. Lee,T. M. Kim,I. Kim,H. K. Ahn,H. C. Jeung, S. I. Lee,S. Y. Oh,W. K. Bae,H. Ryu, K. H. Park,K. H. Lee

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S359-S360

引用0浏览0引用

A Phase 1, 2 Study to Evaluate the Safety and Antitumor Activity of JIN-A02 in Patients with EGFR Mutant Advanced NSCLC

S. M. Lim,B. C. Cho,M. Nagasaka,T. Reungwetwattana,A. Jo,E. Seah, C. Kim,S. -H. I. Ou

JOURNAL OF THORACIC ONCOLOGY（2023）

引用0浏览0引用

P2.09-09 A Phase 1, 2 Study to Evaluate the Safety and Anti-tumor Activity of JIN-A02 in Patients with EGFR Mutant Advanced NSCLC

S.M. Lim,B.C. Cho,M. Nagasaka,T. Reungwetwattana,A. Jo,E. Seah, C. Kim,S.-H.I. Ou

Journal of Thoracic Oncologyno. 11 (2023): S335

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn